MANNELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 18.499
EU - Europa 11.068
AS - Asia 7.029
SA - Sud America 1.057
AF - Africa 200
OC - Oceania 147
Continente sconosciuto - Info sul continente non disponibili 5
Totale 38.005
Nazione #
US - Stati Uniti d'America 18.260
RU - Federazione Russa 3.428
IT - Italia 2.236
SG - Singapore 1.911
PL - Polonia 1.645
CN - Cina 1.506
HK - Hong Kong 1.228
SE - Svezia 876
IE - Irlanda 862
VN - Vietnam 851
BR - Brasile 828
KR - Corea 617
DE - Germania 457
UA - Ucraina 394
FI - Finlandia 319
FR - Francia 318
IN - India 253
GB - Regno Unito 216
BD - Bangladesh 154
AU - Australia 141
CA - Canada 140
JO - Giordania 115
AR - Argentina 97
CH - Svizzera 89
ID - Indonesia 66
NL - Olanda 66
TR - Turchia 63
JP - Giappone 61
IQ - Iraq 46
EC - Ecuador 44
ES - Italia 41
MX - Messico 40
CI - Costa d'Avorio 34
BE - Belgio 33
NG - Nigeria 33
ZA - Sudafrica 33
CO - Colombia 26
AT - Austria 22
MA - Marocco 19
PK - Pakistan 19
VE - Venezuela 19
PY - Paraguay 18
CR - Costa Rica 16
SC - Seychelles 15
EG - Egitto 13
PH - Filippine 13
CZ - Repubblica Ceca 12
DZ - Algeria 12
MY - Malesia 12
NP - Nepal 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
TN - Tunisia 10
LT - Lituania 9
AL - Albania 7
AZ - Azerbaigian 7
JM - Giamaica 7
KE - Kenya 7
KG - Kirghizistan 7
UY - Uruguay 7
HN - Honduras 6
IL - Israele 6
NZ - Nuova Zelanda 6
PE - Perù 6
PS - Palestinian Territory 6
AM - Armenia 5
BG - Bulgaria 5
BJ - Benin 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HU - Ungheria 5
NI - Nicaragua 5
RO - Romania 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
KZ - Kazakistan 4
OM - Oman 4
SN - Senegal 4
TH - Thailandia 4
AO - Angola 3
EU - Europa 3
GR - Grecia 3
MD - Moldavia 3
MU - Mauritius 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
BZ - Belize 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
KW - Kuwait 2
MK - Macedonia 2
PT - Portogallo 2
RS - Serbia 2
Totale 37.977
Città #
Santa Clara 2.571
Ashburn 1.993
Fairfield 1.963
Warsaw 1.638
Singapore 1.382
Hong Kong 1.020
Woodbridge 937
Chandler 863
Dublin 861
Seattle 794
Cambridge 782
Dallas 717
Houston 703
Jacksonville 639
Wilmington 625
Seoul 612
San Jose 507
Milan 496
Ann Arbor 362
Beijing 353
Princeton 261
Lawrence 254
Ho Chi Minh City 251
Hefei 243
Los Angeles 236
Altamura 231
Buffalo 223
Lauterbourg 204
The Dalles 198
Hanoi 187
Rome 185
Florence 177
Moscow 165
Boston 164
Boardman 159
Mumbai 157
Council Bluffs 138
Melbourne 137
Medford 122
New York 115
Munich 112
San Diego 99
Shanghai 86
Bern 84
Helsinki 64
West Jordan 62
Dong Ket 59
Bologna 57
Naples 56
Paris 54
São Paulo 54
Tokyo 53
Turku 51
Clifton 47
Kent 47
Redondo Beach 46
Jakarta 45
Toronto 43
Turin 43
Norwalk 42
Amsterdam 41
Haiphong 40
Falls Church 36
Izmir 35
Abidjan 34
Chicago 34
Brussels 32
Da Nang 32
London 31
Orem 31
Hillsboro 30
Abuja 29
Brooklyn 29
Phoenix 28
Frankfurt am Main 27
Montreal 26
Rio de Janeiro 26
Figino 25
Guangzhou 23
Andover 22
Palermo 22
Voghera 22
Yubileyny 22
Chennai 20
Johannesburg 20
Baghdad 19
Pune 19
Venice 19
Bari 18
Belo Horizonte 18
Genoa 18
Hải Dương 18
Prato 18
Vienna 18
Barcelona 17
Atlanta 16
Campinas 16
Biên Hòa 15
Bremen 15
Buenos Aires 15
Totale 25.805
Nome #
(0) Save to: more options SPECT semiquantitative analysis of adrenocortical. I-131-6 beta-iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma 1.346
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 359
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 356
Incidental and metastatic adrenal masses 344
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 324
Metformin as a new anti-cancer drug in adrenocortical carcinoma 314
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 305
Feasibility and safety of minimal-incision thyroidectomy for Graves' disease: A prospective, single-center study 303
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 296
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 290
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. 290
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 286
A case of malignant insulinoma responsive to somatostatin analogs treatment 253
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model 253
A unique neuroendocrine cell model derived from the human foetal neural crest. 237
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 233
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 233
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 232
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 232
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 228
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 223
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells. 218
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 217
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 212
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 211
A case of hyponatremia caused by central hypocortisolism 211
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 206
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 202
Il dosaggio delle metanefrine nella diagnosi del feocromocitoma: vantaggi clinici e problematiche di laboratorio 202
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 197
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 194
Rare diseases in clinical endocrinology: a taxonomic classification system. 194
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. 193
Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study 192
Adrenal incidentaloma: the influence of a decision-making algorithm on the short-term outcome of laparoscopy 191
Analysis of circulating microRNAs in adrenocortical tumors. 191
Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules 191
A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress. 189
Effects of prostaglandin E2 inhibition on norepinephrine plasma levels after adrenergic stimulation in man. 189
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 187
Genetic screening for pheochromocytoma: should SDHC gene analysis be included? 186
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. 186
Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection 185
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 185
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. 185
A further case of giant intrasellar carotid aneurysm mimicking a pituitary adenoma: the relevance of a multivariate approach in differential diagnosis. 184
Effects of thyroid replacement therapy on catecholamine plasma levels. 183
Adrenal medulla secretion in Cushing's syndrome. 183
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 183
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 182
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 182
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 181
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 181
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 181
Caratterizzazione genomica del carcinoma surrenalico 180
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 180
The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells 178
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma 177
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 177
Presence and distribution of endothelin-1 gene expression in human kidney. 177
Pheochromocytoma in Italy: a multicentric retrospective study. 175
Localization of endothelin-converting enzyme-1 in human kidney 175
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. 175
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 174
Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture 174
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 173
Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas. 172
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 171
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 170
[Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications] 169
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 169
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 169
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 168
A prospective study of the prevelence of primary aldosteronism in 1,125 hypertensive patients 168
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? 168
Adjuvant mitotane treatment for adrenocortical carcinoma 168
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 168
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. 167
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 167
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 166
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 165
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 164
False serum calcitonin high levels using a non-competitive two-site IRMA. 164
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. 164
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 164
Ipertensione ed esercizio fisico 162
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 162
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 162
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism 162
Functional significance of germline EPAS1 variants 162
[Diagnostic problems in pheochromocytoma] 161
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 161
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma 161
Integrated genomic characterization of adrenocortical carcinoma. 161
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer 160
Functional study in a yeast model of a novel succinate-dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. 159
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. 159
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 157
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 157
SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma 157
Totale 20.990
Categoria #
all - tutte 103.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.583 49 134 119 69 72 94 54 120 95 93 256 428
2022/20233.928 418 695 179 278 317 718 497 184 380 29 121 112
2023/20241.381 65 156 252 79 98 166 35 241 27 122 92 48
2024/20258.711 344 1.043 596 1.480 2.342 865 151 624 419 221 312 314
2025/202611.666 1.126 1.713 1.260 939 1.114 414 1.291 581 690 651 275 1.612
2026/2027248 248 0 0 0 0 0 0 0 0 0 0 0
Totale 38.244